MORRIS PLAINS, N.J., June 4, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, will be presenting at the Jefferies 2010 Global Life Sciences Conference, scheduled for Wednesday, June 9 at 8:30 am in New York, NY.
